… cancer drug delivery strategies that exploit nanotechnology, providing first an overview of
tumor biology … circumvented limitations in the delivery of cancer therapeutics, related to their …

… This may be one of the causes of failure of randomized trials to demonstrate a significant
beneficial effect of neoadjuvant chemotherapy in head and neck cancer to date. Thus far, with …

… was well tolerated and the clinical results served as the basis to further elucidate the potential
role of WBH as and adjunct to systemic chemotherapy in advanced cancer patients [39]. …

… The potential of metronomic chemotherapy was revealed in … of metronomic chemotherapy
in a variety of human cancers. … of metronomic chemotherapy in adult and pediatric cancer …

… cancer types. Therefore, as the emerging interest in use of DNMT inhibitors as a potential
chemo… The present article will provide a brief review of the biological significance and rationale …

… cancer chemotherapy with liposomes, as with cancer chemo… approach is legitimate where
cancer is genuinely a systemic … the apparently systemic nature of cancer "from its inception" (14…

… Yet 4 large randomized phase III trials of chemotherapy with … tion studies of chemotherapy
plus monoclonal antibodies … topic and explore the biologic rationale for developing new …

… for many orally formulated cancer cytotoxics. While these findings are observed for all
classes of oral drugs, the issue is especially critical for cancer chemotherapy, in which a narrow …

… The combination of chemotherapy and … cancers. Table 1 displays exemplarily possible
mechanisms how HT is capable of increasing the efficacy of certain classes of chemotherapeutic …

… of cancer affect the delivery and interactions of anti-cancer nanomedicines … cancer biological
properties that challenge the currently available anti-cancer treatments, including cancer …